Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.

Pichler I, Del Greco M F, Gögele M, Lill CM, Bertram L, Do CB, Eriksson N, Foroud T, Myers RH; PD GWAS Consortium, Nalls M, Keller MF; International Parkinson's Disease Genomics Consortium; Wellcome Trust Case Control Consortium 2, Benyamin B, Whitfield JB; Genetics of Iron Status Consortium, Pramstaller PP, Hicks AA, Thompson JR, Minelli C.

PLoS Med. 2013;10(6):e1001462. doi: 10.1371/journal.pmed.1001462. Epub 2013 Jun 4. Erratum in: PLoS Med. 2013 Jun;10(6). doi:10.1371/annotation/c4d81646-0c0e-4a3e-9425-b220bae2d8b6.

2.

The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.

Gill D, Del Greco M F, Walker AP, Srai SKS, Laffan MA, Minelli C.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1788-1792. doi: 10.1161/ATVBAHA.117.309757. Epub 2017 Jul 6.

3.

Serum iron level and kidney function: a Mendelian randomization study.

Del Greco M F, Foco L, Pichler I, Eller P, Eller K, Benyamin B, Whitfield JB; Genetics of Iron Status Consortium; CKDGen Consortium, Pramstaller PP, Thompson JR, Pattaro C, Minelli C.

Nephrol Dial Transplant. 2017 Feb 1;32(2):273-278. doi: 10.1093/ndt/gfw215.

4.

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G; International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW.

PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.

5.

Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.

Hartwig FP, Borges MC, Horta BL, Bowden J, Davey Smith G.

JAMA Psychiatry. 2017 Dec 1;74(12):1226-1233. doi: 10.1001/jamapsychiatry.2017.3191.

PMID:
29094161
6.

No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.

Larsson SC, Singleton AB, Nalls MA, Richards JB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2017 Aug;32(8):1249-1252. doi: 10.1002/mds.27069. Epub 2017 Jun 8.

7.

Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.

Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H.

Parkinsonism Relat Disord. 2015 Sep;21(9):1087-92. doi: 10.1016/j.parkreldis.2015.07.006. Epub 2015 Jul 10.

8.

Mendelian randomization of serum urate and parkinson disease progression.

Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A; Parkinson Study Group.

Ann Neurol. 2014 Dec;76(6):862-8. doi: 10.1002/ana.24281. Epub 2014 Oct 3.

9.

Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.

Prins BP, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N, Stuart PE, Guterriez Achury J, Mistry V, Bradfield JP, Valdes AM, Bras J, Shatunov A; PAGE Consortium; International Stroke Genetics Consortium; Systemic Sclerosis consortium; Treat OA consortium; DIAGRAM Consortium; CARDIoGRAMplusC4D Consortium; ALS consortium; International Parkinson’s Disease Genomics Consortium; Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium; CKDGen consortium; GERAD1 Consortium; International Consortium for Blood Pressure; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Inflammation Working Group of the CHARGE Consortium, Lu C, Han B, Raychaudhuri S, Bevan S, Mayes MD, Tsoi LC, Evangelou E, Nair RP, Grant SF, Polychronakos C, Radstake TR, van Heel DA, Dunstan ML, Wood NW, Al-Chalabi A, Dehghan A, Hakonarson H, Markus HS, Elder JT, Knight J, Arking DE, Spector TD, Koeleman BP, van Duijn CM, Martin J, Morris AP, Weersma RK, Wijmenga C, Munroe PB, Perry JR, Pouget JG, Jamshidi Y, Snieder H, Alizadeh BZ.

PLoS Med. 2016 Jun 21;13(6):e1001976. doi: 10.1371/journal.pmed.1001976. eCollection 2016 Jun.

10.

Association between sex, systemic iron variation and probability of Parkinson's disease.

Mariani S, Ventriglia M, Simonelli I, Bucossi S, Siotto M, Donno S, Vernieri F, Squitti R.

Int J Neurosci. 2016;126(4):354-60. doi: 10.3109/00207454.2015.1020113. Epub 2015 Jul 14.

PMID:
26000822
11.

Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications.

Jiao J, Guo H, He Y, Wang J, Yuan J, Hu W.

Brain Res. 2016 Sep 1;1646:490-493. doi: 10.1016/j.brainres.2016.06.044. Epub 2016 Jun 29.

PMID:
27372885
12.

Impact of atopy on risk of glioma: a Mendelian randomisation study.

Disney-Hogg L, Cornish AJ, Sud A, Law PJ, Kinnersley B, Jacobs DI, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS.

BMC Med. 2018 Mar 15;16(1):42. doi: 10.1186/s12916-018-1027-5.

13.

Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes.

Kennedy AE, Kamdar KY, Lupo PJ, Okcu MF, Scheurer ME, Baum MK, Dorak MT.

Leuk Res. 2014 Sep;38(9):1055-60. doi: 10.1016/j.leukres.2014.06.016. Epub 2014 Jul 11.

PMID:
25085015
14.

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C.

Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.

15.
16.

Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population.

Gan W, Guan Y, Wu Q, An P, Zhu J, Lu L, Jing L, Yu Y, Ruan S, Xie D, Makrides M, Gibson RA, Anderson GJ, Li H, Lin X, Wang F.

Am J Clin Nutr. 2012 Mar;95(3):626-32. doi: 10.3945/ajcn.111.025684. Epub 2012 Feb 1.

PMID:
22301935
17.

Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan NA, Thompson JR.

Int J Epidemiol. 2016 Dec 1;45(6):1961-1974. doi: 10.1093/ije/dyw220.

18.

Childhood adiposity and risk of type 1 diabetes: A Mendelian randomization study.

Censin JC, Nowak C, Cooper N, Bergsten P, Todd JA, Fall T.

PLoS Med. 2017 Aug 1;14(8):e1002362. doi: 10.1371/journal.pmed.1002362. eCollection 2017 Aug.

19.

Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study.

Galesloot TE, Geurts-Moespot AJ, den Heijer M, Sweep FC, Fleming RE, Kiemeney LA, Vermeulen SH, Swinkels DW.

J Med Genet. 2013 Sep;50(9):593-8. doi: 10.1136/jmedgenet-2013-101673. Epub 2013 Jun 21.

PMID:
23794717
20.

The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.

Xia J, Xu H, Jiang H, Xie J.

Neurosci Lett. 2015 May 19;595:99-103. doi: 10.1016/j.neulet.2015.04.010. Epub 2015 Apr 8.

PMID:
25863172

Supplemental Content

Support Center